APA Zitierstil

Dridi, S., Hirano, Y., Tarallo, V., Kim, Y., Fowler, B. J., Ambati, B. K., . . . Ambati, J. (2012). ERK1/2 activation is a therapeutic target in age-related macular degeneration. National Academy of Sciences.

Chicago Zitierstil

Dridi, Sami, et al. ERK1/2 Activation Is a Therapeutic Target in Age-related Macular Degeneration. National Academy of Sciences, 2012.

MLA Zitierstil

Dridi, Sami, et al. ERK1/2 Activation Is a Therapeutic Target in Age-related Macular Degeneration. National Academy of Sciences, 2012.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.